Picture of PeptiDream logo

4587 PeptiDream Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for PeptiDream, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

2019
June 30th
2020
December 31st
C2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,8076,0203,8046,6534,353
Depreciation
Amortisation
Non-Cash Items-39.11,226412220311
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital192-6,0841,806-8,9305,324
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities4,4811,7336,655-82.912,421
Capital Expenditures-195-586-1,215-3,975-1,369
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1,064-614-1,069-23,4022,672
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,259-1,200-2,283-27,3771,303
Financing Cash Flow Items-0.00121.5-213-38
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities28.5-23766.120,789264
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3,3481634,597-6,49914,260